Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.26) per share. This is a 92.93 percent increase over losses of $(3.68) per share from the same period last year.
Mizuho Maintains Buy on Rivian Automotive, Lowers Price Target to $37
Mizuho analyst Vijay Rakesh maintains Rivian Automotive (NASDAQ:RIVN) with a Buy and lowers the price target from $42 to $37.